Are We Ready for Whole Population Genomic Sequencing of Asymptomatic Newborns?

References

• Berg JS, Agrawal PB, Bailey DB, et al. Newborn sequencing in genomic medicine and public health. Pediatrics. 2017;139(2). doi:10.1542/peds.2016-2252
   Web of Science ®Google Scholar
• O’Leary P, Maxwell S. Newborn bloodspot screening policy framework for Australia. Australas Med J. 2015;8(9):292–298. doi:10.4066/amj.2015.2482
   PubMedGoogle Scholar
• Powell CM. What is newborn screening? N C Med J. 2019;80(1):32–36. doi:10.18043/ncm.80.1.32
   PubMedGoogle Scholar
• Therrell BL, Padilla CD. Newborn screening in the developing countries. Curr Opin Pediatr. 2018;30(6):734–739. doi:10.1097/mop.0000000000000683
   PubMed Web of Science ®Google Scholar
• Therrell BL, Padilla CD, Loeber JG, et al. Current status of newborn screening worldwide: 2015. Semin Perinatol. 2015;39(3):171–187. doi:10.1053/j.semperi.2015.03.002
   PubMed Web of Science ®Google Scholar
• Wilcken B, Wiley V. Fifty years of newborn screening. J Paediatr Child Health. 2015;51(1):103–107. doi:10.1111/jpc.12817
   PubMed Web of Science ®Google Scholar
• Hussain Z. Over £175m investment in genomic research aims to detect more genetic disorders at birth. BMJ. 2022;379:o2996. doi:10.1136/bmj.o2996
   PubMedGoogle Scholar
• Patel KP, Ruiz-Cordero R, Chen W, et al. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): clinical next-generation sequencing results within 48 hours of sample collection. J Mol Diagnos. 2019;21(1):89–98. doi:10.1016/j.jmoldx.2018.08.002
   PubMed Web of Science ®Google Scholar
• Goenka SD, Gorzynski JE, Shafin K, et al. Accelerated identification of disease-causing variants with ultra-rapid nanopore genome sequencing. Nat Biotechnol. 2022;40(7):1035–1041. doi:10.1038/s41587-022-01221-5
   PubMed Web of Science ®Google Scholar
• Kingsmore SF, Cakici JA, Clark MM, et al. A randomized, controlled trial of the analytic and diagnostic performance of singleton and trio, rapid genome and exome sequencing in ill infants. Am J Hum Genet. 2019;105(4):719–733. doi:10.1016/j.ajhg.2019.08.009
   PubMed Web of Science ®Google Scholar
• Lunke S, Eggers S, Wilson M, et al. Feasibility of ultra-rapid exome sequencing in critically ill infants and children with suspected monogenic conditions in the Australian public health care system. JAMA. 2020;323(24):2503–2511. doi:10.1001/jama.2020.7671
   PubMed Web of Science ®Google Scholar
• Dimmock DP, Clark MM, Gaughran M, et al. An RCT of rapid genomic sequencing among seriously ill infants results in high clinical utility, changes in management, and low perceived harm. Am J Hum Genet. 2020;107(5):942–952. doi:10.1016/j.ajhg.2020.10.003
   PubMed Web of Science ®Google Scholar
• Denommé-Pichon AS, Vitobello A, Olaso R, et al. Accelerated genome sequencing with controlled costs for infants in intensive care units: a feasibility study in a French hospital network. Eur J Human Genet. 2022;30(5):567–576. doi:10.1038/s41431-021-00998-4
   PubMed Web of Science ®Google Scholar
• Kraft SA, Duenas D, Wilfond BS, Goddard KAB. The evolving landscape of expanded carrier screening: challenges and opportunities. Genet Med. 2019;21(4):790–797. doi:10.1038/s41436-018-0273-4
   PubMed Web of Science ®Google Scholar
• Archibald AD, McClaren BJ, Caruana J, et al. The Australian Reproductive Genetic Carrier Screening Project (Mackenzie’s Mission): design and implementation. J Personal Med. 2022;12(11):1781.
   PubMed Web of Science ®Google Scholar
• Rowe CA, Wright CF. Expanded universal carrier screening and its implementation within a publicly funded healthcare service. J Community Genet. 2020;11(1):21–38. doi:10.1007/s12687-019-00443-6
   PubMed Web of Science ®Google Scholar
• Dive L, Newson AJ. Ethics of reproductive genetic carrier screening: from the clinic to the population. Public Health Ethics. 2021;14(2):202–217. doi:10.1093/phe/phab017
   PubMed Web of Science ®Google Scholar
• Dive L, Archibald AD, Newson AJ. Ethical considerations in gene selection for reproductive carrier screening. Hum Genet. 2022;141(5):1003–1012. doi:10.1007/s00439-021-02341-9
   PubMed Web of Science ®Google Scholar
• Newson AJ. The promise of public health ethics for precision medicine: the case of newborn preventive genomic sequencing. Hum Genet. 2022;141(5):1035–1043. doi:10.1007/s00439-021-02269-0
   PubMed Web of Science ®Google Scholar
• Adhikari AN, Gallagher RC, Wang Y, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020;26(9):1392–1397. doi:10.1038/s41591-020-0966-5
   PubMed Web of Science ®Google Scholar
• Kirk EP, Ong R, Boggs K, et al. Gene selection for the Australian Reproductive Genetic Carrier Screening Project (“Mackenzie’s Mission”). Eur J Human Genet. 2021;29(1):79–87. doi:10.1038/s41431-020-0685-x
   PubMed Web of Science ®Google Scholar
• Davidov B, Levon A, Volkov H, et al. Pathogenic variant-based preconception carrier screening in the Israeli Jewish population. Clin Genet. 2022;101(5–6):517–529. doi:10.1111/cge.14131
   PubMed Web of Science ®Google Scholar
• Wilson J, Jungner G. Principles and Practice of Screening for Disease. World Health Organization; 1968.
   Google Scholar
• King JR, Notarangelo LD, Hammarström L. An appraisal of the Wilson & Jungner criteria in the context of genomic-based newborn screening for inborn errors of immunity. J Allergy Clin Immunol. 2021;147(2):428–438. doi:10.1016/j.jaci.2020.12.633
   PubMed Web of Science ®Google Scholar
• Andermann A, Blancquaert I, Beauchamp S, Costea I. Guiding policy decisions for genetic screening: developing a systematic and transparent approach. Public Health Genomics. 2011;14(1):9–16. doi:10.1159/000272898
   PubMed Web of Science ®Google Scholar
• Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ. 2008;86(4):317–319. doi:10.2471/blt.07.050112
   PubMed Web of Science ®Google Scholar
• Genomics England. New public dialogue finds support for the use of whole genome sequencing in newborn screening – providing that the right safeguards and resources are in place. Available from: https://www.genomicsengland.co.uk/news/public-dialogue-genomics-newborn-screening. Accessed June 20, 2023.
   Google Scholar
• Cao M, Notini L, Ayres S, Vears DF. Australian healthcare professionals’ perspectives on the ethical and practical issues associated with genomic newborn screening. J Genet Couns. 2022;32(2):376–386. doi:10.1002/jgc4.1645
   PubMed Web of Science ®Google Scholar
• Ulm E, Feero WG, Dineen R, Charrow J, Wicklund C. Genetics professionals’ opinions of whole-genome sequencing in the newborn period. J Genet Couns. 2015;24(3):452–463. doi:10.1007/s10897-014-9779-3
   PubMed Web of Science ®Google Scholar
• Boardman FK, Clark CC. What is a ‘serious’ genetic condition? The perceptions of people living with genetic conditions. Eur J Human Genet. 2022;30(2):160–169. doi:10.1038/s41431-021-00962-2
   PubMed Web of Science ®Google Scholar
• Franková V, Driscoll RO, Jansen ME, et al. Regulatory landscape of providing information on newborn screening to parents across Europe. Eur J Human Genet. 2021;29(1):67–78. doi:10.1038/s41431-020-00716-6
   PubMed Web of Science ®Google Scholar
• Nicholls SG, Etchegary H, Tessier L, et al. What is in a name? Parent, professional and policy-maker conceptions of consent-related language in the context of newborn screening. Public Health Ethics. 2019;12(2):158–175. doi:10.1093/phe/phz003
   PubMed Web of Science ®Google Scholar
• Etchegary H, Nicholls SG, Tessier L, et al. Consent for newborn screening: parents’ and health-care professionals’ experiences of consent in practice. Eur J Human Genet. 2016;24(11):1530–1534. doi:10.1038/ejhg.2016.55
   PubMed Web of Science ®Google Scholar
• King E, Halliday J, Archibald AD, et al. Development and use of the Australian reproductive genetic carrier screening decision aid. Eur J Human Genet. 2022;30(2):194–202. doi:10.1038/s41431-021-00991-x
   PubMed Web of Science ®Google Scholar
• Shickh S, Hirjikaka D, Clausen M, et al. Genetics Adviser: a protocol for a mixed-methods randomised controlled trial evaluating a digital platform for genetics service delivery. BMJ open. 2022;12(4):e060899. doi:10.1136/bmjopen-2022-060899
   PubMedGoogle Scholar
• Bombard Y, Clausen M, Shickh S, et al. Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: a randomized clinical trial. Genet Med. 2020;22(4):727–735. doi:10.1038/s41436-019-0702-z
   PubMed Web of Science ®Google Scholar
• Bouffler SE et al . (2023). Two-step offer and return of multiple types of additional genomic findings to families after ultrarapid trio genomic testing in the acute care setting: a study protocol. BMJ Open, 13(6), e072999 10.1136/bmjopen-2023-072999
   PubMed Web of Science ®Google Scholar
• Horton R, Lucassen A. Ethical Considerations in Research with Genomic Data. New Bioeth. 2022;1–15. doi:10.1080/20502877.2022.2060590
   PubMedGoogle Scholar
• Newson A. Should parental refusals of newborn screening be respected? Cambridge Quarter Healthcare Ethics. 2006;15(2):135–146. doi:10.1017/s0963180106060166
   PubMed Web of Science ®Google Scholar
• Paul D. Contesting consent: the challenge to compulsory neonatal screening for PKU. Perspect Biol Med. 1999;42(2):207–219. doi:10.1353/pbm.1999.0032
   PubMed Web of Science ®Google Scholar
• Gillam L. The zone of parental discretion: an ethical tool for dealing with disagreement between parents and doctors about medical treatment for a child. Clin Ethics. 2016;11:1–8. doi:10.1177/1477750915622033
   Google Scholar
• Vears DF. Should we respect parents’ views about which results to return from genomic sequencing? Hum Genet. 2022;141(5):1059–1068. doi:10.1007/s00439-021-02293-0
   PubMed Web of Science ®Google Scholar
• Gyngell C, Lynch F, Stark Z, Vears D. Consent for rapid genomic sequencing for critically ill children: legal and ethical issues. Monash Bioeth Rev. 2021;39(Suppl 1):117–129. doi:10.1007/s40592-021-00146-0
   PubMed Web of Science ®Google Scholar
• Taylor-Robinson D, Kee F. Precision public health-The Emperor’s new clothes. Int J Epidemiol. 2019;48(1):1–6. doi:10.1093/ije/dyy184
   PubMed Web of Science ®Google Scholar
• Notini L, Gaff C, Savulescu J, Vears DF. Offering and returning secondary findings in the context of exome sequencing for hearing loss: clinicians’ views and experiences. AJOB Empir Bioethics. 2023;1–10. doi:10.1080/23294515.2022.2160507
   Google Scholar
• Anderson JA, Meyn MS, Shuman C, et al. Parents perspectives on whole genome sequencing for their children: qualified enthusiasm? J Med Ethics. 2017;43(8):535–539. doi:10.1136/medethics-2016-103564
   PubMed Web of Science ®Google Scholar
• Downie L, Halliday J, Lewis S, et al. Exome sequencing in newborns with congenital deafness as a model for genomic newborn screening: the Baby Beyond Hearing project. Genet Med. 2020;22(5):937–944. doi:10.1038/s41436-019-0745-1
   PubMedGoogle Scholar
• Schmidt JL, Castellanos-Brown K, Childress S, et al. The impact of false-positive newborn screening results on families: a qualitative study. Genet Med. 2012;14(1):76–80. doi:10.1038/gim.2011.5
   PubMed Web of Science ®Google Scholar
• Conway M, Vuong TT, Hart K, Rohrwasser A, Eilbeck K. Pain points in parents’ interactions with newborn screening systems: a qualitative study. BMC Pediatr. 2022;22(1):167. doi:10.1186/s12887-022-03160-1
   PubMed Web of Science ®Google Scholar
• Bowman-Smart H, Vears DF, Brett GR, Martyn M, Stark Z, Gyngell C. ‘Diagnostic shock’: the impact of results from ultrarapid genomic sequencing of critically unwell children on aspects of family functioning. Eur J Human Genet. 2022;30(9):1036–1043. doi:10.1038/s41431-022-01140-8
   PubMed Web of Science ®Google Scholar
• Notini L, Gaff CL, Savulescu J, Vears DF. Clinicians’ views and experiences with offering and returning results from exome sequencing to parents of infants with hearing loss. J Clin Med. 2021;11(1):35. doi:10.3390/jcm11010035
   PubMed Web of Science ®Google Scholar
• Preston J, VanZeeland A, Peiffer DA. Innovation at Illumina: the road to the $600 human genome. Nature Portfolio; 2021.
   Google Scholar
• Howard HC, Knoppers BM, Cornel MC, et al. Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Eur J Human Genet. 2015;23(12):1593–1600. doi:10.1038/ejhg.2014.289
   PubMed Web of Science ®Google Scholar
• Appelbaum PS, Parens E, Berger SM, Chung WK, Burke W. Is there a duty to reinterpret genetic data? The ethical dimensions. Genet Med. 2020;22(3):633–639. doi:10.1038/s41436-019-0679-7
   PubMed Web of Science ®Google Scholar
• Rahimzadeh V, Friedman JM, de Wert G, Knoppers BM. Exome/genome-wide testing in newborn screening: a proportionate path forward. Perspective. Front Genet. 2022;13. doi:10.3389/fgene.2022.865400
   Web of Science ®Google Scholar